Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimating national-level measles case fatality ratios: an updated systematic review and modelling study

Alyssa N. Sbarra, Jonathan F. Mosser, Mark Jit, View ORCID ProfileAllison Portnoy
doi: https://doi.org/10.1101/2022.10.05.22280730
Alyssa N. Sbarra
1Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine
2Institute of Health Metrics and Evaluation, University of Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asbarra@uw.edu
Jonathan F. Mosser
2Institute of Health Metrics and Evaluation, University of Washington
3Department of Health Metrics Sciences, University of Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Jit
1Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison Portnoy
4Center for Health Decision Science, Harvard T.H. Chan School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allison Portnoy
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To understand current and prevent future measles mortality burden, it is critical to have robust estimates of measles case fatality. Dynamic estimates of measles case fatality ratios (CFR) that are age-, location-, and time-specific are essential to capture variation in underlying population-level factors that contribute systematically to increases or decreases in case fatality, such as vaccination coverage and measles incidence. In this study, we updated estimates of measles CFR by expanding upon previous systematic reviews and implementing a meta-regression model.

Methods We conducted a literature review of all available data on measles case fatality from 1980 through 2019 from low- and middle-income countries and ages and extracted the most granular information available on measles cases and deaths. Using this data and a suite of covariates related to measles CFR, we implemented a Bayesian meta-regression model to produce estimates of measles CFR by location and age from 1990 to 2019.

Findings We identified 245 literature sources that contained information on measles cases and deaths. In 2019, we estimated a mean CFR among community-based settings of 1.32% (95% Uncertainty Interval (UI): 1.28 – 1.36%) and among hospital-based settings a mean of 5.35% (95% UI: 5.08 – 5.64%). In community-based settings, we estimated 2019 CFRs to be 3.03% (95% UI: 2.89 – 3.16%) among under-one year olds, 1.63% (95% UI: 1.58 – 1.68%) among 1 to 4 year olds, 0.84% (95% UI: 0.80 – 0.87%) among 5 to 9 year olds, and 0.67% (95% UI: 0.64 – 0.70%) among 10 to 14 year olds. Between 1990 and 2019, we estimated measles vaccination has averted approximately 49 million deaths due to measles mortality.

Interpretation While CFRs have improved, there are still large heterogeneities across locations and ages. Our updated methodologic framework and estimates can be used to evaluate measles control and vaccination programs to reduce preventable measles mortality burden.

Evidence before this study Two previous systematic reviews have synthesized individual studies of measles CFR. The first review, by Wolfson et al., was published in 2009. It used 58 community-based studies in 29 countries to provide global estimates of measles CFR. Using descriptive methods, the Wolfson analysis published results suggesting global estimates of CFR with a mean of 3.3%, with a median of 3.9%, and range from 0 – 40.1%. For outbreak investigations, results suggested a median CFR of 5.2% (95% CI: 2.6 – 11.6%). These results were the first to produce figures of measles CFR beyond single country-year studies, reports, and investigations; however, this study only included community-based studies, did not produce estimates for other locations or years, and did not further stratify by other underlying determinants of mortality, such as development status of each country.

The later review by Portnoy and others was published in 2019 and included data from 1980 to 2016 from low- and middle-income countries; studies included reports from both community-based (n=85) and hospital-based (n=39) settings. Following the review, authors used a log-linear prediction model with a select set of covariates, understood to be related to measles CFR (previous vaccination history [first dose MCV coverage used as a proxy], estimated measles attack rate) and indirectly associated with measles CFR (under-5 mortality [U5M], total fertility rate, proportion of population living in urban areas, population density). The authors reported predicted CFR stratified by year, country-development status, under-5 mortality rate, community versus hospital, and for ages under- or over-5 years, as well as by calendar year from 1990 to 2030. Results predicted a mean CFR of 2.2% (95% CI: 0.7 – 4.5%) for years 1990–2015, with stratification for community (CFR: 1.5, 95% CI: 0.5 – 3.1%) and hospital-based studies (CFR: 2.9, 95% CI: 0.9 – 6.0%).

Added value of this study Our study updates the existing body of evidence to assess measles CFR on a global scale. To synthesize these data along with a suite of covariates demonstrated to be related to measles CFR at the population level according to the published literature, we implemented a Bayesian meta-regression modelling framework, with a flexible spline component to better capture variation in CFR by age, to produce age-, location- and year-specific estimates of measles CFR from 1990 to 2019.

Implications of all the available evidence This model, along with corresponding estimates, can contribute to a deeper understanding of measles CFR and allow for a more robust assessment of vaccination programmes and other interventions to reduce measles mortality burden.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Bill & Melinda Gates Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study used only openly available human data previously published in the public domain.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors and will be published publicly at time of future publication in journal.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted October 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimating national-level measles case fatality ratios: an updated systematic review and modelling study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimating national-level measles case fatality ratios: an updated systematic review and modelling study
Alyssa N. Sbarra, Jonathan F. Mosser, Mark Jit, Allison Portnoy
medRxiv 2022.10.05.22280730; doi: https://doi.org/10.1101/2022.10.05.22280730
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Estimating national-level measles case fatality ratios: an updated systematic review and modelling study
Alyssa N. Sbarra, Jonathan F. Mosser, Mark Jit, Allison Portnoy
medRxiv 2022.10.05.22280730; doi: https://doi.org/10.1101/2022.10.05.22280730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1774)
  • Dentistry and Oral Medicine (239)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10824)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2962)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1935)
  • Health Policy (836)
  • Health Systems and Quality Improvement (746)
  • Hematology (294)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12530)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2815)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (258)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (869)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (339)
  • Psychiatry and Clinical Psychology (2650)
  • Public and Global Health (5386)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (598)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (293)
  • Sports Medicine (279)
  • Surgery (328)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (127)